Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins

Cancer Research

Volumn 69, Issue 11, 2009, Pages 4861-4869

  Richardson, Douglas S ^a   Gujral, Taranjit S ^a   Peng, Susan ^a   Asa, Sylvia L ^b   Mulligan, Lois M ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN RET;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CCDC6 GENE; CELL PROLIFERATION; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NCOA4 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; RET GENE;

CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYTOSKELETAL PROTEINS; HELA CELLS; HUMANS; NEOPLASM PROTEINS; ONCOGENE PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-RET; RNA, MESSENGER; THYROID NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 66349136514     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4425     Document Type: Article

References (38)

1. Arighi E, Borrello MG, Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev 2005;16:441-467 (Pubitemid 41022013)
2. Mulligan LM, Kwok JBJ, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458-460 (Pubitemid 23179393)
3. Hofstra RMW, Landsvater RM, Ceccherini I, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994;367:375-376 (Pubitemid 2025549)
4. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985;42:581-588 (Pubitemid 16091150)
5. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006;6:292-306.
6. Castellone MD, Santoro M. Dysregulated RET signaling in thyroid cancer. Endocrinol Metab Clin North Am 2008;37:363-74, viii.
7. DeLellis RA, Lloyd, RV, Heitz, PU, Eng, C, editors. Pathology and genetics of tumors of endocrine origin. 1st ed. Lyon: IARC Press; 2004.
8. Soares P, Fonseca E, Wynford-Thomas D, Sobrinho-Simoes M. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J Pathol 1998;185:71-78
9. Rhoden KJ, Unger K, Salvatore G, et al. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab 2006;91:2414-2423 (Pubitemid 43855035)
10. Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL, Tuttle RM. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 2000;85:1170-1175 (Pubitemid 32269367)
11. Bongarzone I, Vigneri P, Mariani L, Collini P, Pilotti S, Pierotti MA. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin Cancer Res 1998;4:223-228 (Pubitemid 28062900)
12. Santoro M, Carlomagno F, Hay ID, et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 1992;89:1517-1522
13. Gujral TS, Singh VK, Jia Z, Mulligan LM. Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2B. Cancer Res 2006;66:10741-10749 (Pubitemid 44876969)
14. Gujral TS, van Veelen W, Richardson DS, et al. A novel RET kinase-β-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma. Cancer Res 2008;68:1338-1346
15. Vasko V, Espinosa AV, Scouten W, et al. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci US A 2007;104:2803-2808 (Pubitemid 46327960)
16. Shishido T, Akagi T, Ouchi T, Georgescu MM, Langdon WY, Hanafusa H. The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc Natl Acad Sci US A 2000;97:6439-6444 (Pubitemid 30412732)
17. Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S. Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene 1995;10:2367-2377
18. Treier M, Staszewski LM, Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 1994;78:787-798 (Pubitemid 24294454)
19. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int 2004;11:36-42. (Pubitemid 43863211)
20. Chitayat S, Adams JJ, Furness HS, Bayer EA, Smith SP. The solution structure of the C-terminal modular pair from Clostridium perfringens A-toxin reveals a noncellulosomal dockerin module. J Mol Biol 2008;381:1202-1212
21. Spencer DM, Graef I, Austin DJ, Schreiber SL, Crabtree GR. A general strategy for producing conditional alleles of Src-like tyrosine kinases. Proc Natl Acad Sci U S A 1995;92:9805-9809
22. Casar B, Pinto A, Crespo P. Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes. Mol Cell 2008;31:708-721
23. Wiley HS, Burke PM. Regulation of receptor tyrosine kinase signaling by endocytic trafficking. Traffic 2001;2:12-18 (Pubitemid 32219853)
24. Richardson DS, Lai AZ, Mulligan LM. RET ligand-induced internalization and its consequences for downstream signaling. Oncogene 2006;25:3206-3211 (Pubitemid 43881561)
25. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 1991;266:21327-21330 (Pubitemid 121000182)
26. Castellone MD, De Falco V, Rao DM, et al. The β-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. Cancer Res 2009;69:1867-1876.
27. Cassinelli G, Favini E, Degl'Innocenti D, et al. RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involveMet induction and β-catenin nuclear translocation. Neoplasia 2009;11:10-21.
28. Schuringa JJ, Wojtachnio K, Hagens W, et al. MEN2ARET-induced cellular transformation by activation of STAT3. Oncogene 2001;20:5350-5358 (Pubitemid 32844066)
29. Scott RP, Eketjall S, Aineskog H, Ibanez CF. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase. J Biol Chem 2005;280:13442-13449 (Pubitemid 40517232)
30. Fang D, Liu YC. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol 2001;2:870-875
31. Krawczyk C, Bachmaier K, Sasaki T, et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 2000;13:463-473
32. Ettenberg SA, Keane MM, Nau MM, et al. cbl-b inhibits epidermal growth factor receptor signaling. Oncogene 1999;18:1855-1866 (Pubitemid 29145853)
33. Melikova MS, Kondratov KA, Kornilova ES. Two different stages of epidermal growth factor (EGF) receptor endocytosis are sensitive to free ubiquitin depletion produced by proteasome inhibitor MG132. Cell Biol Int 2006;30:31-43. (Pubitemid 43253726)
34. Longva KE, Blystad FD, Stang E, Larsen AM, Johannessen LE, Madshus IH. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J Cell Biol 2002;156:843-854 (Pubitemid 34839867)
35. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 1998;83:4116-4122 (Pubitemid 28513605)
36. Hickey JG, Myers SM, Tian X, et al. RET-mediated gene expression pattern is affected by isoform but not oncogenic mutation. Genes Chromosomes Cancer 2009;48:429-440
37. Lamorte L, Park M. The receptor tyrosine kinases: role in cancer progression. Surg Oncol Clin N Am 2001;10:271-88, viii. (Pubitemid 32472530)
38. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007;7:233-245 (Pubitemid 46480968)